New combo therapy aims to tame overactive blood production
NCT ID NCT07445893
First seen Mar 05, 2026 · Last updated May 07, 2026 · Updated 13 times
Summary
This study tests whether a new drug (gecacitinib) plus a standard medicine (pegylated interferon) can help people with polycythemia vera, a condition where the body makes too many blood cells. The main goal is to see if the combination can bring blood counts back to normal levels after 24 weeks of treatment. About 30 adults will take part and be closely monitored.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYTHEMIA VERA (PV) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.